Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients-Reference-Cited by-同舟云学术

Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients

Published:2017-06-13 Issue:6 Volume:77 Page:448-453
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Guarino Maria¹,Di Costanzo Giovan G.²,Gallotta Andrea³,Tortora Raffaella¹,Paneghetti Laura³,Auriemma Francesco¹,Tuccillo Concetta⁴,Fassina Giorgio³,Caporaso Nicola¹,Morisco Filomena¹

Affiliation:

1. Department of Clinical Medicine and Surgery, Gastroenterology Unit, University of Naples Federico II, Naples, Italy;

2. Liver Unit, ‘A.Cardarelli’ Hospital, Naples, Italy;

3. XeptagenSpA, Venice, Italy;

4. Department of Clinical and Experimental Medicine ‘F. Magrassi and A. Lanzara’, Gastroenterology Unit, Second University of Naples, Naples, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2017.1336569

Reference41 articles.